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The relative abilities of an avirulent Salmonella typhimurium strain with wild-type lipopolysaccharide (LPS)
character, SL5319, and a nearly isogenic LPS-deficient mutant, SL5325, to colonize the large intestines of
streptomycin-treated CD-1 mice in vivo and to penetrate colonic mucus in vitro were studied. Previously it had
been shown that, when fed simultaneously to streptomycin-treated mice (approximately 1010 CFU each), the S.
typhimurium strain with wild-type LPS colonized at 108 CFU/g of feces indefinitely, whereas the LPS-deficient
mutant dropped within 3 days to a level of only 104 CFU/g of feces. In the present investigation, when SL5325
was allowed to colonize for 8 days before feeding mice SL5319 or when it was fed to mice simultaneously with
an Escherichia coli strain of human fecal origin (1010 CFU each), both strains colonized indefinitely at 107
CFU/g of feces. Moreover, when the wild-type and LPS-deficient mutant strains were fed to mice simultaneously in low numbers (approximately 105 CFU each) the strains survived equally well in the large intestines
for 8 days, after which the LPS-deficient mutant was eliminated (<102 CFU/g of feces), whereas the wild-type
colonized at a level of 107 CFU/g of feces. In addition although both strains were able to adhere to mucus and
epithelial cell preparations in vitro, the wild-type strain was shown to have greater motility and chemotactic
activity on CD-1 mouse colonic mucus in vitro and to more rapidly penetrate and form a stable association with
immobilized colonic mucosal components in vitro. Based on these data, we suggest that the ability of an S.
typhimurium strain to colonize the streptomycin-treated mouse large intestine may, in part, depend on its
ability to penetrate deeply into the mucus layer on the intestinal wall and subsequently, through growth,
colonize the mucosa.

A wide variety of bacteria colonize the large intestines of
humans and animals. The bacterial populations involved
consist of hundreds of species which for any given mammalian host interact in such a way as to achieve a relatively
stable numerical balance (8, 17). Freter and co-workers have
performed elegant experiments both in vivo and in continuous-flow cultures in vitro which suggest that the ability of a
bacterium to persist in the large intestine under limiting
nutrient conditions in part depends on its ability to colonize
the intestinal wall (14, 15, 17). According to the model, if two
nearly isogenic strains are able to grow equally well in the
lumen of the intestine but only one is able to colonize the
intestinal wall, that one would be the better large intestine
colonizer since under limiting nutrient conditions it would be
protected against washout in feces.
In a few instances intestinal wall mucus has been implicated in either the normal bacterial colonization process or
in disease states caused by gram-negative intestinal pathogens. For example, the ability of Vibrio cholerae to colonize
mouse and rabbit small intestine mucosa has been positively
correlated with its ability to associate with and grow in the
mucus layer (13, 16). Furthermore, the ability of a normal
human fecal Escherichia coli strain to colonize the mouse
large intestine has been positively correlated with its ability
to bind to mucus glycoprotein (4), and enterotoxigenic E.
coli strains have been shown to bind avidly to intestinal
mucus (24, 25). In addition, the ability of Shigella flexneri to
invade HeLa cells in vitro has recently been shown to be
*

inhibited by guinea pig but not monkey colonic mucus (6),
and some virulent Campylobacter strains have been shown
to bind avidly to both rabbit small and large intestine mucus
(26).
Antibiotic treatment of animals is known to increase their
susceptibility to colonization by exogenous antibioticresistant, enteric gram-negative bacteria in general (10, 11);
in the case of S. typhimurium it has been shown that
streptomycin treatment increases its ability to colonize the
mouse large intestine about 100,000-fold (3, 33). Taking
advantage of this fact, we were recently able to show that
when an avirulent S. typhimurium strain and lipopolysaccharide (LPS)-deficient mutants derived from it were placed in
direct competition with one another in streptomycin-treated
mice, their relative intestinal colonizing abilities were found
to decrease as their LPS structure became more defective
(30). In the present investigation, we show that the defect in
the ability of an LPS-deficient mutant to colonize is in
initiating and not in maintaining that state. Furthermore we
show that both the wild-type S. typhimurium strain and its
LPS-deficient mutant grow equally well together in the
streptomycin-treated mouse large intestine, but that differences in their relative abilities to initiate colonization may be
related to differences in their relative abilities to form a
stable association with the mucosal surface.
MATERIALS AND METHODS

Bacteria. S. typhimurium SL5316, which contains wildtype LPS, is streptomycin resistant (Strr), requires histidine
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experiment was performed at least twice with essentially
identical results.
Media and antibiotics. L broth was made as described by
Revel (34). L agar is L broth containing 12 g of Bacto-Agar
(Difco Laboratories, Detroit, Mich.) per liter. Streptomycin
sulfate, nalidixic acid, tetracycline, and rifampin were purchased from Sigma Chemical Co., St. Louis, Mo. Modified
Davis minimal medium is the sulfur-free medium described
previously (4), but in addition it contained 50 ,ug each of
L-histidine, L-leucine, L-phenylalanine, L-tryptophan, and
L-tyrosine per ml and 1 ,ug each of p-aminobenzoic acid,
p-hydroxybenzoic acid, and 2,3-dihydroxybenzoic acid per
ml all necessary for growth of the S. typhimurium strains
(30). L motility agar is L broth containing 3.5 mg of BactoAgar per ml of water. Mucus motility agar contains 3 mg of
colonic mucus, 1 ,ug each of p-aminobenzoic acid, phydroxybenzoic acid, and 2,3-dihydroxybenzoic acid, and
3.5 mg of Difco agar purified per ml of HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) plus Hanks balanced salt solution (HEPES-Hanks buffer), pH 7.4.
Crude mucus isolation. Crude mucus was isolated from the
colons of 5- to 8-week-old male CD-1 mice by scraping the
walls of excised colon into HEPES-Hanks buffer (pH 7.4) as
described previously (4) and centrifuging away (4°C) the
epithelial cells and membranes twice at 12,000 x g for 10 min
and once at 27,000 x g for 15 min. Crude mucus preparations
were microscopically (970x) free of visible epithelial cells.
Colonic epithelial cell preparation. Intestinal cells from the
mouse colon were prepared by the method of Weiser (37).
Twenty-four hours before use the mice were deprived of
food and given sterile water containing streptomycin sulfate
(5 g/liter). Routinely 10 to 15 mice were employed. The final
suspension was 4.0 x 106 epithelial cells per ml in 24.5 mM
HEPES buffer (pH 7.5) containing 2.5 mM monosodium
phosphate and 98 mM sodium chloride.
Although the method of Weiser was originally developed
for isolation of epithelial cells from the rat small intestine
(37), the method works well for isolation of epithelial cells
from both the CD-1 mouse small intestine (25) and the colon.
Typically, an entire colon yields about 5 x 106 cells. The
majority (at least 75 to 80%) appear to be columnar epithelial
cells. As pointed out previously (12), it is difficult to ensure
that the epithelial cells are free of mucus; indeed, microscopically the cells appear to have a small amount of mucus
associated with them.
Mucus and epithelial cell immobilization. Mucus was immobilized as described previously (4). Briefly, 0.25-ml samples of mucus (0.5 mg of protein per ml) were added to
multiwell polystyrene tissue culture plates (Linbro 24-well
flat-bottom tissue culture plates with a well diameter of 1.6
cm; Flow Laboratories, McLean, Va.), and the plates were
incubated overnight at 4°C. After incubation for 1 h at 37°C,
the wells were washed twice with 0.5 ml of HEPES-Hanks
buffer (pH 7.4) to remove unbound protein. Plates containing
bovine serum albumin (BSA) were prepared identically,
except that 0.25 ml of BSA (0.5 mg/ml) was added to the
wells. Colonic epithelial cells (4.0 x 106 cells per ml, 0.25 ml
per well) were immobilized as described above for mucus.
The epithelial cells, although not viable as determined by
trypan blue uptake, remained intact upon immobilization
and formed a homogeneous layer of cells, each surrounded
by mucus, on the bottom of each well. Wells containing
either immobilized colonic epithelial cells or colonic mucus,
when treated with Coomassie brillant blue to detect immobilized proteins, stained uniformly blue, whereas untreated
wells remained colorless after staining.
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and leucine for growth, and is avirulent because of an aroA
defect (30). Strain SL5319 is a tetracycline-resistant (Tetr)
derivative of SL5316 caused by insertion of TnJO into its
chromosome and also has the wild-type LPS character (30).
SL5316 and SL5319 have identical growth requirements and
colonize streptomycin-treated mice equally well (30), and
both will hereafter be referred to as wild type. Strain SL5325
is an rfaJ derivative of SL5316 (30). In the experiments
reported here, a spontaneous nalidixic acid-resistant (Nalr)
mutant of SL5325 was used (30). This strain, SL5325 (Strr
Nalr), and its parent, SL5325 (Strr), have identical colonizing
abilities in streptomycin-treated mice (30). The Salmonella
strains used here are of the FIRN biotype, which does not
have type 1 pili (7). E. coli F-18 (Strr Rif) is a mutant of a
normal fecal strain isolated from a healthy University of
Rhode Island student in 1977.
Mouse colonization experiments. We routinely used male
CD-1 mice (5 to 8 weeks old), which were given drinking
water containing streptomycin sulfate (5 g/liter). After 1 day
of streptomycin treatment, the count of facultative bacteria
dropped from about 108 CFU/g of feces to less than 102
CFU/g of feces, whereas the count of anaerobic bacteria
remained constant at about 109 CFU/g of feces (30). Mice
were then held overnight without food or water. Depending
on the experiment, one of the following three protocols was
followed thereafter.
(i) Precolonization with S. typhimurium SL5325 followed by
challenge with S. typhimurium SL5319. The morning after
starvation, three individually housed mice were fed approximately 1010 CFU of the LPS-deficient mutant strain SL5325
in 1 ml of sterile 20% (wt/vol) sucrose. The mice drank the
bacterial suspension almost immediately and were then
returned to and maintained on their normal diet (Charles
River Valley Rat, Mouse, Hamster Formula), including
sterile drinking water containing streptomycin (5 g/liter). The
next day and at 48-hour intervals thereafter, 1 g of feces, no
older than 24 h, was collected from each mouse, homogenized in 10 ml of L broth, diluted, and plated on selective
agar media as described previously (30). On day 7, the mice
were again held overnight without food and water, and the
next morning they were fed about 1010 CFU of the wild-type
strain, SL5319, as described above. The mice were then
returned to their normal diet, including water containing
streptomycin, and the next day and at 48-h intervals thereafter fecal samples were diluted and plated as described
above.
(ii) Simultaneous feeding of S. typhimurium SL5325 and E.
coli F-18. The morning after food and water were withheld,
three individually housed mice were fed about 1010 CFU
each of the LPS-deficient mutant S. typhimurium SL5325
and E. coli F-18. The mice were then returned to their
normal diet, and the next morning and at 48-h intervals fresh
fecal samples were homogenized, diluted, and plated as
described above.
(iii) Wild-type S. typhimurium and LPS mutant strain
SL5325 competition in mice fed 105 CFU of each strain. The
morning after food and water were withheld, three individually housed mice were fed about 105 CFU each of the
wild-type strain SL5319 and the LPS-deficient mutant
SL5325. The mice were then returned to their normal diet as
described above, and the next morning and at 24-h or 48-h
intervals thereafter fecal samples were collected, homogenized, diluted, and plated as described above. Plates in all
colonization experiments were incubated at 37°C from 18 to
24 h before counting. Colonizing ability was assessed by the
level at which a strain persisted in feces. Each colonization
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the means.
RESULTS
In vivo colonization. Recently, we reported that when 1010
CFU each of an avirulent S. typhimurium strain with wild-

type LPS character and an LPS-deficient mutant derived
from it, SL5325, were fed simultaneously to streptomycintreated mice, the wild-type strain persisted in feces indefinitely at 108 CFU/g of feces, whereas the LPS-deficient
mutant dropped from 108 to 104 CFU/g of feces within 3 days
and colonized indefinitely thereafter at a level of 103 CFU/g
of feces (30). When fed alone to mice the LPS-deficient
mutant colonized at a level of about 107 CFU/g of feces (30).
To learn more about the relative colonizing abilities of the
wild-type S. typhimurium and its LPS-deficient mutant three
additional colonization experiments were performed.
(i) Precolonization of streptomycin-treated mice with an
LPS-deficient mutant before challenge with the wild-type
strain. Streptomycin-treated mice were fed 1010 CFU of the
LPS-deficient mutant S. typhimurium SL5325 and 8 days
later were fed 1010 CFU of the wild-type strain. Under these
conditions, over the next 13 days the LPS mutant remained
at about 107 CFU/g of feces, and the wild-type strain
colonized at about the same level (Fig. 1). Thus, when the
LPS-deficient mutant was given time to successfully colonize, it had no trouble maintaining that state in the face of
competition from its wild-type parent.
(ii) S. typhimurium SL5325 competition with E. coli F-18 in
streptomycin-treated mice. Streptomycin-treated mice were
simultaneously fed 1010 CFU each of the LPS-deficient
mutant strain SL5325 and E. coli F-18, a normal human fecal
E. coli strain (4, 5). Each strain colonized at a level of about
107 CFU/g of feces indefinitely (Fig. 2). The same result was
obtained when SL5325 competed against a different human
fecal E. coli strain, E. coli F-17 (28); i.e., both colonized at
107 CFU/g of feces (data not shown). Therefore, the LPSdeficient mutant is a defective colonizer only when competing against a related Salmonella strain, not when competing
against unrelated E. coli strains.
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FIG. 1. Stability of SL5325 in vivo when fed to mice before
SL5319. Three streptomycin-treated mice were fed 1010 CFU of the
LPS-deficient mutant (0) SL5325 (Strr Nalr). At the indicated time
(arrow), the same mice were fed 1010 CFU of the wild-type strain (0)
SL5319 (Strr Tetr). Fecal samples were plated as described in
Materials and Methods. Counts (mean values + standard errors) are
expressed as log1o numbers of CFU per gram of feces.
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Radioactive labeling of S. typhimurium. Cultures of the S.
typhimurium strains were labeled in modified Davis minimal
medium as described previously (4). 35SO4-labeled cultures
were washed twice with HEPES-Hanks buffer (pH 7.4) at
4°C and suspended in the same buffer at 37°C at about 5 x
108 cells per ml. The specific activity of the cells was
routinely between 2 x 10-3 and 1 x 10-2 cpm/CFU, depending on the age of the 35SO4.
Adhesion assay. The adhesion assay has been described
previously (4, 24, 25). Prewarmed (37°C) radioactive S.
typhimurium cells (0.2 ml, 5.0 x 108 cells per ml) were added
to each well, and the plates were incubated for 1 h at 37°C.
The wells were then washed twice with 0.5-ml samples of
HEPES-Hanks buffer (pH 7.4) to remove nonadherent bacteria. Adherent bacteria were recovered by adding 0.5 ml of
5% sodium dodecyl sulfate to each well and reincubating the
plates at 37°C for 3 h. The sodium dodecyl sulfate was
removed from each well, and the level of radioactivity was
determined by scintillation counting.
Radioactive bacteria released less than 0.5% of the total
incorporated label during the 1-h incubation period. Furthermore, subsequent incubation of supernatants failed to produce significant levels of radioactivity adhering to mucus
(<250 cpm).
In vitro penetration of S. typhimurium through mucus.
Polystyrene wells containing immobilized colonic epithelial
cells were prepared as described above. Colonic mucus (0.5
ml, 4.1 mg of protein per ml) was then added to each well
above the epithelial cells, forming a distinct layer. Samples
of an S. typhimurium strain (0.2 ml, 5 x 108 CFU/ml) labeled
with 35 O4 were then carefully layered atop the mucus in the
wells. The samples were then incubated at 37°C for 1.5, 3.0,
5.0, 7.0, and 18.0 h. At each time, a set of two wells was
aspirated once to remove bacteria still in the mucus layer but
leave any bacteria which had penetrated through and
reached the mucus-epithelial cell interface, and a second set
of two wells was aspirated as above and washed twice with
1 ml of HEPES-Hanks buffer (pH 7.4) to remove all bacteria
which had penetrated mucus but were not firmly bound to
the epithelial cell layer. The adherent bacteria remaining in
each set of wells were then collected and counted as described above.
As a control, polystyrene wells containing immobilized
colonic epithelial cells were exposed to the same 35 o4labeled S. typhimurium strain (0.2 ml per well); at 1.5 and 18
h, the bacteria at the HEPES-Hanks buffer (pH 7.4)-epithelial cell interface and the bacteria firmly bound to the
epithelial cell layer were collected and counted as described
above.
Motility. Strains to be tested for motility were streaked on
L agar and incubated for 18 h at 37°C. At that time, samples
of each strain were transferred with a sterile toothpick from
L agar to L motility agar and mucus motility agar. Plates
were incubated at 37°C, and diameters of visible spread were
measured (30).
Statistics. Where indicated below, groups of duplicate or
triplicate values were compared by Student's t test (P
values), and the arithmetic means of specific time points
were compared by linear regression analysis (correlation
coefficients). Bars in the graphs represent standard errors of

VOL. 55, 1987

SALMONELLA COLONIZATION

TABLE 1. Adhesion of the S. typhimurium wild-type and
LPS-deficient mutant strains to immobilized colonic
mucus, epithelial cell preparation, and BSA
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Adhesion (mean cpm + SE)a
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LPS-deficient
mutant
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a
Data are from triplicate samples. The specific activities of the wild-type
strain and the LPS-deficient mutant were essentially identical (i.e., 1.1 x 10-2
cpm/CFU).
I Ratio of adhesion of the LPS mutant to that of the wild
type.
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FIG. 2. Colonization of streptomycin-treated mice with E. coli
F-18 and S. typhimurium SL5325. E. coli F-18 (Strr RifT) (0) and S.
typhimurium SL5325 (Strr Nall) (0) were fed simultaneously to each
of three streptomycin-treated mice (1010 CFU each). At the indicated times, fecal samples were plated as described in Materials and
Methods.

(iii) Wild-type S. lyphimurium strain SL5319 and LPSdeficient mutant strain SL5325 competition in mice fed 105
CFU of each strain. When streptomycin-treated mice were
simultaneously fed 105 CFU each of the wild type and the
LPS-deficient mutant strain, i.e., 100,000-fold fewer than in
previous experiments, both strains persisted in about equal
numbers in feces for about 8 days (Fig. 3), i.e., about three
times as long as when mice were fed 1010 CFU of each strain
(30). After 8 days, however, the wild-type strain increased
100-fold in numbers, whereas the LPS mutant was rapidly
eliminated, i.e., to <102 CFU/g of feces (Fig. 3). These data
suggested that some factor other than the relative abilities of
the two strains to withstand the environment in the mouse
large intestine was responsible for their disparate colonizing
abilities.
Adhesion and the ability of the S. typhimurium strains to
form a close association with the mucosal surface in vitro. It is
becoming increasingly clear that association with the intestinal mucosal surface may be an important factor in colonization (14, 15, 17). Although undoubtedly a complex process, the establishment of such an association presumably
involves penetration to the deeper portions of the mucus
layer and perhaps adhesion to the underlying epithelial cells.
With this in mind, we attempted, first, to assess the abilities
of the strains to adhere to mucosal components immobilized
on polystyrene and, second, to assess in vitro the ability of
each strain to adhere to and form a stable association with
immobilized components after passing through a layer of
colonic mucus. Each experiment in this section was performed at least three times. Typical results are shown in
Table 1 and Fig. 4 and 5.
Both strains were capable of binding to mucus and epithe-
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1,222

t
t
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4,444

t
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1,880
689
460

5.14
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3.64

lial cell preparations immobilized on polystyrene (Table 1).
In the case of the wild-type strain, binding to the mucus or
epithelial cell preparations was greater than twice (2.7- and
2.0-fold, respectively) that detected on BSA-treated control
wells (P < 0.05), whereas binding of the LPS-deficient
mutant was approximately three (3.8- and 2.7-fold, respectively) times greater than that of the BSA-treated control
wells (P < 0.05). When adhesion of the two strains was
compared directly, it appeared that the LPS-deficient mutant
bound to all of the immobilized preparations, including the
BSA, at levels three to five times higher than the wild-type
strain (P < 0.05). The apparently greater binding ability of
the LPS-deficient mutant may be due to the fact that the
LPS-deficient mutants are more hydrophobic than the wildtype strain (19). Evidence for such hydrophobicity in the
present case was seen microscopically in the tendency of the
LPS-deficient mutant to form aggregates of 5 to 10 cells
when in suspension, and it may be that the overall higher
levels of adhesion are due, at least in part, to the presence of
bound aggregates.
In the second portion of the in vitro studies, a related but
more complex assay was employed. In this case, the system
employed was designed to measure the relative abilities of
the two strains to travel through a layer of colonic mucus and
subsequently adhere to and establish a stable association
8
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FIG. 3. Colonization of SL5319 and SL5325 in mice fed 105 CFU
of each strain. Streptomycin-treated mice were simultaneously fed
105 CFU each of the wild-type strain (0) SL5319 (Stri Tetr) and the
LPS mutant (0) SL5325 (Strr Nalr). At the indicated times, fecal
samples were plated as described in Materials and Methods. For
clarity, the data from two animals (A and B) are shown individually.
Counts lower than 102 CFU/g of feces are presented as 102 CFU/g of
feces, the lower limit of the assay.
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FIG. 4. Penetration of S. typhimurium strains through mucus to
the mucus-colonic epithelial cell (E.C.) interface in vitro. Data are
presented as the means and standard errors of duplicate samples. In
this experiment the specific activity of the two strains were essentially identical (i.e., 1.1 x 10-2 cpm/CFU). Symbols: OL, wild type;
1. LPS mutant.

with an underlying immobilized epithelial cell preparation.
Penetration was assessed by first layering the wild-type
strain or LPS-deficient mutant atop a layer of mucus. At the
times indicated the mucus was aspirated, and the total
number of bacteria at the mucus-epithelial cell interface, i.e.,
adherent and nonadherent, was determined (Fig. 4). To
assess the level of bacteria closely associated with (adhering
to) the epithelial preparation, the mucus was overlaid and
aspirated as above, and the number of bacteria adhering to
the epithelial cell preparation was determined after two
additional washes (Fig. 5).
During the first 3 h the overall number of wild-type and
LPS-deficient mutant cells continuously increased at the
mucus-epithelial cell interface; however between 1.5 and 7 h
20
ci)
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In a previous report (30) a series of LPS-deficient mutants
derived from S. typhimurium were shown to be poor colonizers of the streptomycin-treated mouse large intestine
when placed in direct competition with the parent strain,
which possessed wild-type LPS. In the present investigation, in vivo studies designed to further characterize the
colonizing properties of the wild-type strain and an LPSdeficient mutant were conducted. Evidence is presented
which illustrates several important points regarding the
relative colonizing abilities of these strains.
First, when mice are simultaneously fed low numbers of
each strain, the LPS-deficient mutant can grow in the
streptomycin-treated mouse large intestine as well as the
wild-type parent (Fig. 3). Only after 8 days does the wildtype parent become the dominant organism. This effectively
rules out the possibility that the wild-type strain is a better
colonizer of the streptomycin-treated mouse large intestine
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TABLE 2. S. typhimurium spreading on motility agar"
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FIG. 5. Adhesion of S. typhimurium strains to the colonic epithelial cell (E.C.) layer after penetration through mucus in vitro.
Data are presented as the means and standard errors of duplicate
samples. The bacterial cultures used are those in Fig. 4. Symbols:
0L, wild type; 12. LPS mutant.

L motility

8
12

24.3 ± 3.1 21.0 ± 1.7
44.7 ± 3.2 41.7 ± 2.1

Mucus motility

10
23

7.0 ± 1.0
14.7 + 1.2

6.7 ± 0.6
12.7 ± 1.2

4.3 + 0.6
12.3 ± 0.6
2.3 ± 0.6
3.7 ± 0.6

Motility assays were performed in triplicate (see Materials and Methods).

bMeasurements are diameters of spread after incubation for the indicated
times at 37°C.
< Wild type LPS.
d rfaJ mutant.
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about 50% of the LPS-deficient mutants returned to the
mucus layer (correlation coefficient, 0.83), whereas the
number of wild-type cells generally increased (correlation
coefficient, 0.81), so that by 7 h there were almost three
times as many wild-type cells as LPS-deficient mutant cells
at the mucus-epithelial cell interface (P < 0.05) (Fig. 4). At
18 h the numbers of wild-type cells at the mucus-epithelial
cell interface were still greater than the number of LPSdeficient mutants (P < 0.05), although the ratio had dropped
from about 3 to 1 to about 1.8 to 1 (Fig. 4). A similar pattern
was observed in wells which were washed twice to remove
unbound bacteria (Fig. 5). Initially (1.5 h) there appeared to
be more LPS-deficient mutants bound (P < 0.05). However,
once again about 50% of the LPS-deficient mutant bound
appeared to return to the mucus layer during the next 3.5 h,
whereas the number of wild-type cells bound to the epithelial
cell preparation increased continuously throughout the experiment (correlation coefficient, 1.0). By 18 h nearly three
times as many wild-type cells as mutant cells were bound to
the epithelial cell preparation (P < 0.05).
Motility. SL5325, the LPS-deficient mutant, has been
reported to be far less motile on L motility agar than its
smooth parent, SL5316, presumably due to a defect in either
flagellar or chemotactic activity (30). In the present study, to
determine whether this defect was also apparent on colonic
mucus, we measured the rate of spreading the two wild-type
strains SL5316 and SL5319 and the LPS-deficient mutant
SL5325 on both L motility agar and mucus motility agar (see
Materials and Methods). In both instances at either time
SL5316 and SL5319 spread far more rapidly (P < 0.01) than
SL5325 (Table 2).
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(Fig. 1).

The wild-type strain, in addition to being a better colonizer, appears to have an advantage over the LPS-deficient
mutant in penetrating mucus in vitro, although this process
and subsequent adhesion to the underlying epithelial cell
layer in vitro appear to be complex processes (Fig. 4 and 5).
That is, at first (1.5 to 3 h) a significant number of LPSdeficient mutants penetrated the mucus layer rapidly (Fig. 4)
and bound to the underlying epithelial cell layer (Fig. 5), but
both penetration and adhesion of these cells seemed to be
reversible in that a large proportion returned to the mucus
layer during the next few hours (Fig. 4 and 5). It is possible
that the initial rapid penetration of the LPS-deficient mutants
was due to aggregates sinking through the mucus, binding,
and subsequently breaking up and returning to the mucus
layer. During and after this time penetration of remaining
LPS-deficient mutants through the mucus to the mucusepithelial cell interface was extremely slow (Fig. 4). In
contrast, the wild-type strain, consisting primarily of single
cells, penetrated the mucus layer and bound to the epithelial
cell layer continuously such that by 18 h nearly three times
as many wild-type cells as LPS-deficient mutant cells were
found bound to the underlying epithelial cell layer (Fig. 4 and
5). In any case, the data suggest a difference in both the rate
at which the two strains can penetrate the mucus layer and,
perhaps more importantly, the rate at which the two strains
form a stable association with the underlying mucosal components.
It should be emphasized that we do not mean to imply that
either the wild-type or LPS-deficient mutant strain necessarily binds specifically to the epithelial cells after penetrating
the mucus layer in vitro. We simply do not know whether the
S. typhimurium strains bind to the epithelial cells, mucus
associated with the epithelial cells, or both. Experiments
designed to resolve this issue are in progress.
How might the relative abilities of the wild-type and
LPS-deficient strains to penetrate mucus and form a stable
association with underlying mucosal components help explain the in vivo colonization data? It is known that both the
large and small intestine walls consist of an epithelium
containing brush border epithelial cells and secretory goblet
cells which synthesize and secrete a relatively thick (up to
400 p.m), viscous, mucus covering (2, 29). The mucus layer
contains mucin, a 2-megadalton, gel-forming glycoprotein
and a large number of smaller glycoproteins, proteins,
glycolipids, and lipids (1, 23, 35). Presumably, shed epithe-
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lial cells are the source of many of the smaller components of
mucus (9, 31, 32, 38). The intestinal mucus layer itself is in a
dynamic state, continuously being synthesized and then
degraded to a large extent by indigenous intestinal microflora
(20, 29). Degraded mucus components are shed into the
lumen of the intestine and eventually find their way into
feces (20, 21, 36, 39). We suggest that the LPS-deficient
mutant penetrates relatively slowly through mucus toward
the underlying epithelial cell layer in vivo, perhaps due to
relatively poor flagellar chemotactic activity (Table 2). Additionally, it is possible that some of the LPS-deficient
mutants which do penetrate mucus in vivo return to the
mucus layer as they do in vitro (Fig. 4 and 5) and are
subsequently eliminated as older mucus is sloughed into the
lumen of the intestine. In contrast, the wild-type strain,
perhaps because it has greater flagellar chemotactic activity
(Table 2), moves more quickly through the mucus layer to
the epithelial cell layer (Fig. 4 and 5), where it binds to
specific Salmonella receptors and grows by using the mucus
layer as a source of carbon and nitrogen. If so, when the
wild-type strain and the LPS-deficient mutant are fed to mice
simultaneously, the wild-type strain would eventually occupy the majority of the available salmonella-specific sites at
the mucus epithelial cell interface and would therefore be the
better colonizer since, as suggested by Freter et al. (14, 15,
17), it would be protected against washout in feces.
We further suggest that when the LPS-deficient mutant is
allowed to colonize for 8 days before mice are fed the
wild-type strain, it has enough time in the absence of
competitor to slowly penetrate the mucus layer, bind at the
mucus-epithelial cell interface, grow, occupy a significant
percentage of Salmonella mucosal receptor sites, and
thereby colonize the intestinal wall. Thus, as observed here
(Fig. 1), when the wild-type strain is subsequently fed to the
mice at day 8 it does not cause elimination of the LPS
mutant.
At the present time we do not understand why feeding
mice 1010 CFU each of the wild-type strain and the LPSdeficient mutant results in an almost immediate elimination
of the LPS-deficient mutant (30) whereas feeding only 105
CFU of each strain results in their existing in equal numbers
for 8 days before the LPS-deficient mutant is eliminated (Fig.
3). However, it is possible that when mice are fed 105 CFU
of each strain we observe the results of growth in the
intestinal lumen for the first 8 days and only thereafter the
effects of disparate colonizing abilities of the intestinal
mucosa. In contrast, when mice are fed 1010 CFU of each
strain, limiting nutrients in the lumen might prevent further
luminal growth, and we therefore observe an almost immediate effect of disparate colonization abilities of the intestinal
mucosa.
Finally, we suggest that E. coli strains do not cause
elimination of the Salmonella LPS-deficient mutant (Fig. 2),
because they bind to different receptors within the intestinal
mucosa and therefore do not prevent one another from
colonizing the intestinal wall. Experiments designed to test
these hypotheses are currently in progress.
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because it possesses an intrinsic advantage relating to the
environmental conditions of the large intestine, e.g., resistance to hydrogen sulfide (14), bacteriocins (22), short-chain
fatty acids (18, 33), or low pH and Eh (3, 27) or an advantage
in competing for limiting nutrients (14, 15), factors suggested
to be operative in the untreated mouse large intestine.
Second, the data indicate (Fig. 2) that there is a degree of
specificity to the competitive aspects of the colonization
process. Although the LPS-deficient mutant is a defective
colonizer relative to the wild-type parent strain, when competing against an unrelated E. coli strain, the LPS-deficient
mutant is an effective colonizer (Fig. 2). Third, it appears
that the defect of the LPS-deficient mutant is related to its
relative ability to initiate colonization in the face of competition from large numbers of the parent strain, rather than in
its ability to maintain colonization. That is, if given an
opportunity to become well established (i.e., 8 days), the
LPS-deficient mutant appears to be able to maintain itself in
relatively high numbers over a significant period of time in
the face of subsequent competition from the wild-type strain
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